BIOMAT Database Logo BIOMAT Database Logo

Experience with biosynthetic human insulin in diabetes. 1983

D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
[Our experience with biosynthetic human insulin].
November 1985, Minerva medica,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
[Treatment of type I diabetes mellitus with biosynthetic human insulin].
September 1985, Bollettino della Societa italiana di biologia sperimentale,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
[Initial treatment of type I diabetes mellitus with biosynthetic human insulin].
May 1983, MMW, Munchener medizinische Wochenschrift,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
Biosynthetic human insulin.
January 1982, The Netherlands journal of medicine,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
Clinical trials with biosynthetic human insulin.
January 1981, Diabetes care,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
Biosynthetic human insulin trials.
August 1980, Nursing mirror,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
[Biosynthetic human insulin: Humulin].
January 1984, Tijdschrift voor ziekenverpleging,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
Biosynthetic Human Insulin and Insulin Analogs.
January 2020, American journal of therapeutics,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
[Initiation and transfer of children to biosynthetic human insulin. Clinical experience].
May 1983, MMW, Munchener medizinische Wochenschrift,
D F Kruger, and F W Whitehouse, and D M Kahkonen, and J O Partamian, and J D Fachnie, and J Goldman, and D Leach
[Biosynthetic human insulin in comparison with conventional intermediary insulin from cattle].
September 1983, Die Medizinische Welt,
Copied contents to your clipboard!